-
MSI Statement on Abortion Clinic ‘Safe Access Zones’
The UK Government has announced that Safe Access Zones around abortion clinics will be implemented from 31st October in England and Wales, preventing anti-choice groups from harassing those seeking and providing abortion care. MSI Reproductive …
-
Charting 25 years of MSI’s programme & abortion rights in Mexico
MSI CEO Simon Cooke writes about his recent visit to the MSI Mexico programme, reflecting on abortion rights in the country.
-
Shanti: I choose choice by providing abortion
Shanti is a nurse, team leader, and abortion provider for MSI Nepal. She tells us more about what abortion care is like in Nepal, and what she hopes for the future of abortion.
-
The Global Effects of Roe v Wade Being Overturned
Women and girls around the world are suffering at the hands of an emboldened global anti-rights movement.
-
MSI launches new digital privacy campaign, the Vagina Privacy Network (VPN), on Dobbs v. Jackson anniversary
WASHINGTON, D.C. / LONDON, June 24, 2024 – MSI Reproductive Choices, a global leader in reproductive health services, has today announced the launch of its new digital reproductive healthcare campaign: Vagina Privacy Network (VPN). Created …
-
MSI Statement on the Second Anniversary of Dobbs
The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.
-
MSI at the Healthy World conference in Canada: linking climate and reproductive health
Working together to mitigate the effects of climate change and help build community resilience — with women’s reproductive health.
-
Briefing: Choice on the Ballot
2024 is the biggest election year in history and reproductive rights hang in the balance.
-
New Guttmacher report shows long-term harms of US Global Gag Rule in Ethiopia and Uganda
The Guttmacher Institute today published a multi-year research study which reveals the U.S. Global Gag Rule (GGR) disrupted critical health services affecting women and girls in Uganda and Ethiopia – two countries that rely on U.S. assistance for their family planning programmes.
-
Advocacy win: Mifepristone registered in Tanzania
MSI and partners have successfully advocated to have mifepristone – the second of two medications used for abortion and post-abortion care – registered and authorised for use in Tanzania.
